A groundbreaking study from QIMR Berghofer Medical Research Institute has unveiled a promising finding - regular use of low dosages of aspirin may significantly improve ovarian cancer survival. This remarkable discovery offers newfound hope in the battle against ovarian cancer, shining a light on the potential benefits of this widely accessible medication in enhancing patient outcome
Read MoreA recent study has shed light on the potential cardiovascular benefits of natural coconut sugar. This research suggests that consuming coconut sugar may help reduce the risk of cardiovascular disease by improving blood vessel health and managing high blood pressure.
Read MoreYear-Round Lyme Disease Risk: How Milder Winters and Reduced Snow Cover Impact Exposure
Read MoreAntibodies aimed at peptides rarely utilized in rheumatoid arthritis (RA) diagnosis have been uncovered to identify untreated early-stage cases, often overlooked by standard biomarkers.
Read MoreExploring innovative tactics, Brigham and Women’s Hospital researchers trialed a Trojan horse strategy: harnessing cancer cells to combat the disease from within.
Read MoreA groundbreaking creation from a South Korean university holds the potential to reshape adherence for individuals with glaucoma, promising revolutionary changes in treatment compliance
Read MoreResearchers from Birjand University of Medical Sciences in Iran have conducted a comprehensive review of previous studies examining cinnamon's impact on cognitive functions. Their analysis underscores cinnamon's potential in mitigating memory and learning impairments
Read MoreResearch has illuminated the longevity-linked form of the BPIFB4 gene (LAV) as linked to extended human lifespans and defensive impacts against cardiovascular disease in animal models. Recent findings indicate LAV-BPIFB4's potential in fostering blood vessel growth and countering cellular senescence, contributing to cardioprotection
Read MoreA recent study reveals that subthalamic deep brain stimulation (DBS) brings significant relief to both patients with and without disease mutations, effectively alleviating motor and non-motor symptoms in early-onset Parkinson's disease.
Read More
